Liu Jia, Lu Xing-Yu, Cheng Lang, Yang Yan, Lin Sheng-Yun, Yin Hua, Liu Xiao-Qing, Wu Xue-Mei, He Guang-Sheng
a Department of hematology , The First people's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University , Changzhou , People's Republic of China.
b Department of hematology , The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine , Nanjing , People's Republic of China.
Hematology. 2019 Dec;24(1):492-497. doi: 10.1080/16078454.2019.1631424.
To evaluate the prognosis of adult severe aplastic anemia (SAA) patients with absolute neutrophil count (ANC) values of zero prior to immunosuppressive therapy (IST). Patients with ANC values of zero prior to IST were separated from very SAA and analyzed in a prospective study. All patients received IST with rabbit anti-thymocyte globulin (ATG) and cyclosporine (CsA). A significantly lower response rate (RR) was identified in patients with ANC = 0 prior to IST when compared to patients with SAA after both 3 and 6 month periods or compared to those with vSAA at 3 months only. The efficacy of IST was inversely related to ANC = 0. The overall survival rate of the 'zero' group was significantly lower than that of the vSAA or SAA groups. Overall survival was closely associated with response to IST, and was inversely related to ANC = 0. In SAA patients, ANC is associated with prognosis, the elucidated overall survival improvement in patients without ANC = 0 occurred in conjunction with decreased infection-related mortality. Our study revealed that adult patients with ANC = 0 prior to IST responded poorly to IST, suggesting that having a very low number of neutrophils was a highly predictive factor for efficacy and survival of SAA patients treated with IST. Adult SAA patients with ANC = 0 had a very poor prognosis and new therapeutic regimens may result in better outcome for these patients.
评估免疫抑制治疗(IST)前中性粒细胞绝对值(ANC)为零的成人重型再生障碍性贫血(SAA)患者的预后。在一项前瞻性研究中,将IST前ANC为零的患者从极重型SAA患者中分离出来并进行分析。所有患者均接受兔抗胸腺细胞球蛋白(ATG)和环孢素(CsA)的IST治疗。与IST后3个月和6个月时的SAA患者相比,或仅与3个月时的极重型SAA患者相比,IST前ANC = 0的患者的缓解率(RR)显著更低。IST的疗效与ANC = 0呈负相关。“零”组的总生存率显著低于极重型SAA组或SAA组。总生存与IST反应密切相关,且与ANC = 0呈负相关。在SAA患者中,ANC与预后相关,在ANC不为零的患者中观察到的总生存改善与感染相关死亡率降低同时出现。我们的研究表明,IST前ANC = 0的成年患者对IST反应不佳,提示中性粒细胞数量极低是接受IST治疗的SAA患者疗效和生存的高度预测因素。IST前ANC = 0的成年SAA患者预后极差,新的治疗方案可能会使这些患者获得更好的结局。